Salivary biomarker guideline for early oral cancer detection

The JADA guideline released on September 28, 2026 recommends the use of salivary liquid biopsy panels for early detection of oral cancers, citing a sensitivity of up to 90% and a specificity of 85%. This evidence‑based protocol can help BDS practitioners screen high‑risk patients more efficiently and refer suspicious lesions earlier, potentially reducing morbidity.